Klaria Pharma Holding
0.439 SEK +8.4%Be the first to follow this company
Klaria Pharma Holding operates in the pharmaceutical industry. The business is focused on developing and commercializing solutions in the therapy areas of migraine and cancer-related pain. The technology is based on the company's drug-delivery platform, where the product consists of the alginate-based polymer film. The film attaches to the patient's oral mucosa, which enables the distribution of pharmaceuticals in the body. The head office is located in Uppsala.
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
Target price
-
Recommendation
-
Updated
-
First North Stockholm
KLAR
Daily low / high price
0.348 / 0.45
SEK
Market cap
56.96M SEK
Turnover
28.83K SEK
Volume
69K
Financial calendar
Interim report
2024-08-22
Interim report
2024-11-21
Major OwnersSource: Millistream Market Data AB
Owner | Capital | Votes |
---|---|---|
Ålandsbanken | 6.7 % | 6.7 % |
Skandinaviska Enskilda Banken | 4.3 % | 4.3 % |
Premium
This content is for our Premium customers only.
ShowingAll content types
Klaria Pharma Holding AB: Klaria Interim Report Q1 2024
Klaria Pharma Holding AB: Klaria Delårsrapport Q1 2024
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools